ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/07/24 | 2,152 | 2,164 | 2,135 | 2,141 | -20 | -0.9% | 24,300 |
| 2024/07/23 | 2,143 | 2,164 | 2,143 | 2,161 | +18 | +0.8% | 29,400 |
| 2024/07/22 | 2,160 | 2,160 | 2,130 | 2,143 | -9 | -0.4% | 29,600 |
| 2024/07/19 | 2,139 | 2,156 | 2,128 | 2,152 | +13 | +0.6% | 42,300 |
| 2024/07/18 | 2,120 | 2,161 | 2,115 | 2,139 | +16 | +0.8% | 51,100 |
| 2024/07/17 | 2,140 | 2,147 | 2,114 | 2,123 | -7 | -0.3% | 32,500 |
| 2024/07/16 | 2,152 | 2,160 | 2,126 | 2,130 | -20 | -0.9% | 32,000 |
| 2024/07/12 | 2,143 | 2,160 | 2,140 | 2,150 | +5 | +0.2% | 57,100 |
| 2024/07/11 | 2,146 | 2,156 | 2,121 | 2,145 | +56 | +2.7% | 72,200 |
| 2024/07/10 | 2,100 | 2,100 | 2,069 | 2,089 | +7 | +0.3% | 45,400 |
| 2024/07/09 | 2,051 | 2,091 | 2,051 | 2,082 | +16 | +0.8% | 37,800 |
| 2024/07/08 | 2,076 | 2,093 | 2,065 | 2,066 | -9 | -0.4% | 37,600 |
| 2024/07/05 | 2,118 | 2,125 | 2,074 | 2,075 | -43 | -2% | 33,700 |
| 2024/07/04 | 2,115 | 2,120 | 2,111 | 2,118 | -1 | ±0% | 17,700 |
| 2024/07/03 | 2,117 | 2,125 | 2,112 | 2,119 | +2 | +0.1% | 22,500 |
| 2024/07/02 | 2,096 | 2,143 | 2,092 | 2,117 | +25 | +1.2% | 75,300 |
| 2024/07/01 | 2,113 | 2,118 | 2,082 | 2,092 | -21 | -1% | 43,400 |
| 2024/06/28 | 2,117 | 2,117 | 2,100 | 2,113 | +3 | +0.1% | 43,500 |
| 2024/06/27 | 2,100 | 2,120 | 2,100 | 2,110 | +10 | +0.5% | 35,700 |
| 2024/06/26 | 2,079 | 2,103 | 2,049 | 2,100 | +21 | +1% | 63,500 |
| 2024/06/25 | 2,100 | 2,103 | 2,069 | 2,079 | -11 | -0.5% | 79,600 |
| 2024/06/24 | 2,076 | 2,100 | 2,076 | 2,090 | +32 | +1.6% | 48,100 |
| 2024/06/21 | 2,086 | 2,097 | 2,051 | 2,058 | -28 | -1.3% | 95,400 |
| 2024/06/20 | 2,088 | 2,098 | 2,069 | 2,086 | +6 | +0.3% | 48,700 |
| 2024/06/19 | 2,059 | 2,091 | 2,059 | 2,080 | +14 | +0.7% | 42,500 |
| 2024/06/18 | 2,080 | 2,088 | 2,057 | 2,066 | +8 | +0.4% | 42,200 |
| 2024/06/17 | 2,066 | 2,067 | 2,023 | 2,058 | -20 | -1% | 36,200 |
| 2024/06/14 | 2,053 | 2,081 | 2,036 | 2,078 | +57 | +2.8% | 99,100 |
| 2024/06/13 | 2,030 | 2,030 | 2,010 | 2,021 | -4 | -0.2% | 33,100 |
| 2024/06/12 | 2,024 | 2,035 | 2,011 | 2,025 | -4 | -0.2% | 26,500 |
| 2024/06/11 | 2,042 | 2,053 | 2,029 | 2,029 | -17 | -0.8% | 41,400 |
| 2024/06/10 | 2,042 | 2,050 | 2,038 | 2,046 | +4 | +0.2% | 28,400 |
| 2024/06/07 | 2,038 | 2,044 | 2,024 | 2,042 | +4 | +0.2% | 60,600 |
| 2024/06/06 | 2,044 | 2,044 | 2,019 | 2,038 | -6 | -0.3% | 48,200 |
| 2024/06/05 | 2,037 | 2,052 | 2,029 | 2,044 | +7 | +0.3% | 61,400 |
| 2024/06/04 | 2,005 | 2,052 | 1,996 | 2,037 | +37 | +1.9% | 82,500 |
| 2024/06/03 | 1,989 | 2,007 | 1,989 | 2,000 | +13 | +0.7% | 39,200 |
| 2024/05/31 | 1,960 | 1,987 | 1,960 | 1,987 | +38 | +1.9% | 72,400 |
| 2024/05/30 | 1,936 | 1,949 | 1,921 | 1,949 | +10 | +0.5% | 50,500 |
| 2024/05/29 | 1,960 | 1,966 | 1,935 | 1,939 | -22 | -1.1% | 45,000 |
| 2024/05/28 | 1,969 | 1,969 | 1,957 | 1,961 | +1 | +0.1% | 24,900 |
| 2024/05/27 | 1,959 | 1,965 | 1,947 | 1,960 | +7 | +0.4% | 40,100 |
| 2024/05/24 | 1,940 | 1,958 | 1,938 | 1,953 | +3 | +0.2% | 38,700 |
| 2024/05/23 | 1,957 | 1,968 | 1,944 | 1,950 | -9 | -0.5% | 74,600 |
| 2024/05/22 | 1,989 | 1,989 | 1,957 | 1,959 | -21 | -1.1% | 52,900 |
| 2024/05/21 | 2,010 | 2,010 | 1,980 | 1,980 | -21 | -1% | 70,700 |
| 2024/05/20 | 2,009 | 2,017 | 2,001 | 2,001 | -8 | -0.4% | 36,400 |
| 2024/05/17 | 1,995 | 2,013 | 1,991 | 2,009 | +9 | +0.5% | 42,900 |
| 2024/05/16 | 2,032 | 2,035 | 1,990 | 2,000 | -25 | -1.2% | 70,000 |
| 2024/05/15 | 2,065 | 2,067 | 2,025 | 2,025 | -20 | -1% | 44,600 |
251～
300
件表示中 / 3754件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 211,700円 | +3.1% | -6.5% | 2.27% | 9.82倍 | 1.04倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ジーエヌアイ | 279,200円 | +21.7% | +999.9% | 0.00% | 11.71倍 | 3.87倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 持田薬 | 323,000円 | +5.1% | -7.0% | 2.48% | 21.20倍 | 0.88倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 154,300円 | -2.4% | -52.3% | 3.69% | 18.47倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 223,600円 | +4.1% | -3.1% | 2.59% | 19.42倍 | 1.69倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
